Open biotechnology may be the ideal solution to ensure scientific progress and the realization of the common good, but it has yet to deliver on its promises. In recent years, an impressive number of ...

Scandinavia's Medicon Valley is experiencing a spurt of funding, prompted by a combination of government and private capital. Obtaining sufficient capital resources for the initial financing of ...